AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MLP SAĞLIK HİZMETLERİ A.Ş.

Capital/Financing Update Dec 7, 2021

8921_rns_2021-12-07_c2bd4240-77b3-450c-98f7-d88f32f9db71.html

Capital/Financing Update

Open in Viewer

Opens in native device viewer

Summary Info Announcement Regarding the CMB Approval of Lease Certificate
Update Notification Flag Yes
Correction Notification Flag No
Postponed Notification Flag No
Authorized Member Decision Date 20.10.2021
Issue Limit 750.000.000
Currency Unit TRY
Issue Limit Security Type Lease Certificates
Sale Type Sale To Qualified Investor
Domestic / Oversea Domestic
Capital Market Board Application Date 02.11.2021
Capital Market Board Application Result APPROVAL
Capital Market Board Approval Date 02.12.2021
Expiry Date of Issue Limit 02.12.2022

Additional Explanations

MLP Sağlık Hizmetleri A.Ş.'s application to the CMB for the issuance of lease certificates and obtaining the necessary permits within the framework of the Capital Markets Board ("CMB") Lease Certificates Communiqué (III-61.1) ("Communiqué") is approved. MLP Sağlık Hizmetleri A.Ş. ("Fund User") would be the fund user of the lease certificates to be issued with various maturities within a one-year period and based on the management contract stipulated in the Communiqué, to be allocated without public offering and sold to qualified investors in one or more times, with an issue ceiling of TL750,000,000 (seven hundred and fifty million TL), and planned to be carried out domestically. Approved issuance certificate is attached. This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.

Supplementary Documents

Appendix: 1 Onaylı İhraç Belgesi.pdf

Talk to a Data Expert

Have a question? We'll get back to you promptly.